ANI Pharmaceuticals Overview
ANI Pharmaceuticals Discounted Cash Flow
DCF Analysis for ANIP.
Get informed when a big investor buys or sells
+ FollowFair Value
$-54.62
Current Fair Value
$-54.62
↓ 166.4% Downside
Overvalued by 166.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison